FI20012565A - Immunosuppressiivisessa terapiassa käytettäviä tuotteita - Google Patents

Immunosuppressiivisessa terapiassa käytettäviä tuotteita Download PDF

Info

Publication number
FI20012565A
FI20012565A FI20012565A FI20012565A FI20012565A FI 20012565 A FI20012565 A FI 20012565A FI 20012565 A FI20012565 A FI 20012565A FI 20012565 A FI20012565 A FI 20012565A FI 20012565 A FI20012565 A FI 20012565A
Authority
FI
Finland
Prior art keywords
immunisuppressive
therapy
products
immunisuppressive therapy
Prior art date
Application number
FI20012565A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20012565A0 (fi
Inventor
Eero Mervaala
Original Assignee
Eero Mervaala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eero Mervaala filed Critical Eero Mervaala
Priority to FI20012565A priority Critical patent/FI20012565A/fi
Publication of FI20012565A0 publication Critical patent/FI20012565A0/fi
Priority to PCT/FI2002/000542 priority patent/WO2003055480A1/fr
Priority to AU2002345121A priority patent/AU2002345121A1/en
Publication of FI20012565A publication Critical patent/FI20012565A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20012565A 2001-12-21 2001-12-21 Immunosuppressiivisessa terapiassa käytettäviä tuotteita FI20012565A (fi)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20012565A FI20012565A (fi) 2001-12-21 2001-12-21 Immunosuppressiivisessa terapiassa käytettäviä tuotteita
PCT/FI2002/000542 WO2003055480A1 (fr) 2001-12-21 2002-06-19 Produits a utiliser dans une therapie immunosuppressive et renfermant de l'acide lipoique et un inhibiteur de la calcineurine
AU2002345121A AU2002345121A1 (en) 2001-12-21 2002-06-19 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20012565A FI20012565A (fi) 2001-12-21 2001-12-21 Immunosuppressiivisessa terapiassa käytettäviä tuotteita

Publications (2)

Publication Number Publication Date
FI20012565A0 FI20012565A0 (fi) 2001-12-21
FI20012565A true FI20012565A (fi) 2003-06-22

Family

ID=8562570

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20012565A FI20012565A (fi) 2001-12-21 2001-12-21 Immunosuppressiivisessa terapiassa käytettäviä tuotteita

Country Status (3)

Country Link
AU (1) AU2002345121A1 (fr)
FI (1) FI20012565A (fr)
WO (1) WO2003055480A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439477C2 (de) * 1994-11-08 1999-10-21 Asta Medica Ag Verwendung von R,S-(+/-)-alpha-Liponsäure, R-(+)-alpha-Liponäure, S-(-)-alpha-Liponsäure in reduzierter oder oxidierter Form oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung der diabetischen Mikroangiopathie
US5990153A (en) * 1997-05-05 1999-11-23 Wood; John G. Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury
WO2001085206A2 (fr) * 2000-05-08 2001-11-15 David Haines Compositions immunosuppressives
DE10030378A1 (de) * 2000-06-21 2002-03-14 Audit Inst For Medical Service Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen
WO2001097832A1 (fr) * 2000-06-21 2001-12-27 Audit Institute For Medical Services And Quality Assurance Gmbh Preparations pharmaceutiques contenant des cylosporines et des huiles neutres
WO2002017959A2 (fr) * 2000-08-28 2002-03-07 Wisconsin Alumni Research Foundation Immunosuppression par utilisation du piceatannol et d'un inhibiteur de la calcineurine

Also Published As

Publication number Publication date
FI20012565A0 (fi) 2001-12-21
AU2002345121A1 (en) 2003-07-15
WO2003055480A1 (fr) 2003-07-10

Similar Documents

Publication Publication Date Title
EE04528B1 (et) Teraapias kasutatavad spirofuropridiinide aralklamiinid
DK1406633T3 (da) Forbedret lægemiddeltilførsel i transdermale systemer
IS2986B (is) Nýr tilbúinn fjölræsivaki til að nota við meðferð á manneskjum
AR028622A1 (es) Derivados de tropano utiles en terapia
NO20054681D0 (no) Farmasoytiske produkter
DE60203429D1 (de) Absorbierender Wegwerfartikel
HK1069349A1 (en) Powered sterile solution device
DE60212066D1 (de) Abgabespritze
BR0209135B1 (pt) artigo de vestir descartável.
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
NO20020531D0 (no) Beta-carbolin medikament produkter
NO20050689L (no) Terapeutisk anvendelse
DE50209245D1 (de) Neuroprotektives medikament
ATE322161T1 (de) Stoffabgabevorrichtung
ATE374011T1 (de) Hautbehandlungsmittel
DE50005409D1 (de) Hör-behandlungsgerät
DE60221068D1 (de) Gerät zur tiefenwirksamen Hauttherapie
FI20012565A (fi) Immunosuppressiivisessa terapiassa käytettäviä tuotteita
AU2003215767A8 (en) Devices for use in medicine
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
EE200300025A (et) CRF2 ligandid kasutamiseks kombineeritud ravis
NO20044090L (no) Substituert 3-fenyl-5-alkoksy-1,3,4-oksadiazol-24neJr, fremstilling derav og anvendelse i medikamenter
SE0101141D0 (sv) Anordning för medicinskt bruk
DE10157913B4 (de) Therapietisch
NO20011711D0 (no) Stol

Legal Events

Date Code Title Description
MA Patent expired